U.S. FDA Accepts New Drug Application Under Priority Review for Takeda's Zasocitinib in Moderate-to-Severe Plaque Psoriasis, with Potential to Redefine Oral Treatment Expectations

MoveSurge carries market-moving headlines the moment they reach the wire, each one with what the price did next.